Kawanishi H, MacDermott R P
Gastroenterology. 1979 Jan;76(1):151-8.
These studies were designed to determine the ability of antihepatocyte antibodies from patients with chronic active liver disease to induce killing of rabbit hepatocytes by normal lymphocytes. Normal subjects and patients with chronic persistent hepatitis or chronic active liver disease served as sources of sera, and normal human peripheral lymphocytes and their subsets (T-enriched, K-enriched, and B) served as effectors. Only sera from patients with chronic active liver disease possessed membrane-reactive IgG directed against the surface of rabbit or human hepatocytes. After pretreatment of rabbit hepatocytes with sera from patients with chronic active liver disease, marked cytotoxicity mediated by normal lymphocytes was observed. K-enriched cells mediated the antibody-dependent cellular cytotoxicity, whereas T-enriched cells and B-cells did not. Heat-aggregated human IgG blocked the antibody-dependent cellular cytotoxicity. These data suggest that sera from patients with chronic active liver disease contain IgG antihepatocyte antibodies, which are capable of inducing normal K-cells to kill rabbit hepatocytes in vitro.
这些研究旨在确定慢性活动性肝病患者的抗肝细胞抗体诱导正常淋巴细胞杀伤兔肝细胞的能力。正常受试者以及慢性持续性肝炎或慢性活动性肝病患者作为血清来源,正常人外周淋巴细胞及其亚群(富含T细胞、富含K细胞和B细胞)作为效应细胞。只有慢性活动性肝病患者的血清含有针对兔或人肝细胞表面的膜反应性IgG。用慢性活动性肝病患者的血清预处理兔肝细胞后,观察到正常淋巴细胞介导的明显细胞毒性。富含K细胞介导抗体依赖性细胞毒性,而富含T细胞和B细胞则不然。热聚集的人IgG可阻断抗体依赖性细胞毒性。这些数据表明,慢性活动性肝病患者的血清含有抗肝细胞IgG抗体,其能够在体外诱导正常K细胞杀伤兔肝细胞。